Equibles does not estimate personal net worth.
Shelley Thunen was last confirmed as CFO at RxSight, Inc. (RXST) in a filing dated April 21, 2025. Shelley Thunen has spoken on 17 earnings calls across 1 company, most recently for RxSight, Inc. on November 5, 2025. The companies whose calls Shelley Thunen spoke on are classified in the Healthcare sector.
“RxCite generated third quarter revenue of $30.3 million, down 14% compared to $35.3 million in the year ago quarter, and down 10% compared to the $33.6 million in the second quarter of 2025.”
“Consistent with our July 8, 2025 pre-announcement, RxSight generated second quarter 2025 revenue of $33.6 million, down 4% compared to $34.9 million in the year-ago quarter and down 11% compared to $37.9 million in the first quarter of 2025.”
“I will briefly review the preliminary first quarter revenue results and updated guidance for the remainder of 2025 that were included in our pre-announcement press release.”
“Consistent with our January pre-announcement, RxSight, Inc. reported fourth quarter 2024 revenue of $40.2 million, up 41% compared to the year-ago quarter. Growth was broad-based, driven by strong growth in LAL procedure volume and the continued expansion of our installed base of LDDs.”
“RxSight generated third quarter 2024 revenue of $35.3 million, up 59% compared to $22.2 million in the year-ago quarter and up 1% compared to $34.9 million in the second quarter of 2024.”
Start not stated–2025-04-21
Last confirmed by a filing; no departure on record
RXST
Medical Devices · Healthcare
CFO
